Published • loading... • Updated
From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma
- A 36-year-old Pakistani patient from Quetta with relapsed diffuse large B-cell lymphoma received personalized CAR-T immunotherapy at a cancer center in Shanghai after failing standard treatments.
- The patient's disease progressed to Stage IVB with widespread metastasis and severe pain by early 2026 despite chemotherapy and a failed bone marrow transplant.
- Dr. Hao Siguo designed a personalized CAR-T therapy plan for the patient through remote consultation, resulting in manageable side effects during treatment.
- The patient experienced only mild cytokine release syndrome without severe neurotoxicity and praised the cooperative and supportive Chinese medical staff.
Insights by Ground AI
48 Articles
48 Articles
Bennington Banner+47 Reposted by 47 other sources
From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma
SHANGHAI, May 24, 2026 /PRNewswire/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, following exhausting standard treatments for aggressive recurrent blood cancer.
Coverage Details
Total News Sources48
Leaning Left7Leaning Right6Center21Last UpdatedBias Distribution62% Center
Bias Distribution
- 62% of the sources are Center
62% Center
L 20%
C 62%
R 18%
Factuality
To view factuality data please Upgrade to Premium
